Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing ...

The next generation in skin resurfacing technology is available to Australian health care practitioners beginning 1 September ...

AI data centre infrastructure's burgeoning energy needs strengthen the long-term uranium outlook, while Boss and Paladin face contrasting operational, funding and valuation challenges ...

FNArena provides a weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX in the ...

Poor trading results from a range of retailers show that, on a per capita basis, the consumer is already under pressure, so ...

CBTW, a global technology solutions company operating across 21 countries, has standardised its governed AI engineering ...

Sigma Healthcare's FY26 result underscored the value of last year's merger with the Chemist Warehouse pharmacy chain ...

September is historically the weakest month for stocks, and on average the S&P500 falls -1.1%. The Australian market eased on ...

The acquisition of the Gawara Baya project represents an opportunity for Copenhagen Infrastructure Partners to deploy near-term capital in Australia and ...

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day ...

A Gold Stevie and three SaaS Awards highlight Payapps' role in helping contractors simplify progress claim submission, assessment and approval.

SIBIONICS showcased its sensor innovation and AI-powered glucose monitoring at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbourne from 18–21 August. Through Booth #1, a ...